Clin2
NCT06580002Possibly a fitRecruiting

Can Riluzole Help with Chemo Brain? A Pilot Study

Breast CancerSarcomaGastric CancerLung CancerHead and Neck CancerColorectal CancerOvarian CancerLiver Cancer

Treatments studied

Part of Blood & lymphatic, Brain & nervous system, Cancer, Digestive system, Heart & circulation, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.

This study tests if a medicine called riluzole (currently used for ALS) can help with 'chemo brain' – memory and thinking problems after cancer treatment. It is for people who feel their mental sharpness has declined after breast cancer therapy, certain chemotherapies, or brain radiation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
75 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • Your thinking or memory has gotten worse since your cancer treatment or brain radiation.
  • You have received either: breast cancer treatment (chemotherapy, radiation, or surgery), or non-breast cancer treatment within the past 3 years, or you have had radiation to your brain for a tumor.
  • You are not currently pregnant or planning pregnancy, and you are not breastfeeding.
  • You do not have serious liver problems or take medications that can interact with the study drug (like certain antibiotics or cannabis).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07447050Recruiting· Phase 2
Riluzole to Prevent Chemo-Related Cognitive Problems

This pilot study tests whether the drug riluzole can help prevent the thinking and memory problems (often called 'chemobrain') that some people experience during chemotherapy. If you are about to start a chemo regimen containing an anthracycline or platinum drug, you may be able to join.

Orange, California
NCT04520139Recruiting· Phase 1/Phase 2
NAC to help prevent chemo brain fog in ovarian cancer

This Phase 1/2 study tests whether taking NAC (a supplement medicine) can help prevent or reduce memory and thinking problems after platinum chemotherapy. It targets people with advanced ovarian, fallopian tube, or primary peritoneal cancer who are starting at least six cycles of platinum-based treatment.

Orange, California
NCT06027632Recruiting
Brain training at home to help with chemo brain after breast cancer treatment

This study tests a supervised computer-based mental exercise program to help reduce memory and thinking problems after chemotherapy. It is for people who finished chemo for early-stage breast cancer and still have bothersome mental fogginess.

Bordeaux
NCT02290834Recruiting
Studying brain and thinking changes after chemotherapy in older breast cancer patients

This study looks at how chemotherapy may affect memory and thinking, using thinking tests and possibly brain imaging. It compares older breast cancer patients who do and do not get chemotherapy, plus a group of healthy older adults.

Boston, Massachusetts
NCT04616300Recruiting
Exercise program to support brain function during breast cancer chemo

This trial studies whether a structured exercise program can help protect or improve thinking and memory in people with breast cancer while they are starting chemotherapy after surgery. It may help with “chemo brain” by targeting brain function during treatment.

Toronto, Ontario
NCT07465497Enrolling by invitation
Preventing Chemo Brain with Prebiotics and Synbiotics

This trial tests whether taking a special blend of prebiotics and synbiotics (friendly bacteria and food for them) can help prevent or reduce memory and thinking problems that sometimes happen during chemotherapy for breast cancer.

Zapopan, Jalisco

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.